ArticleBMC cancer2014

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.

Khalid Abubaker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.